18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US
- Status
- COMPLETED
- Phase
- N/A
MGC018 With or Without MGA012 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
- Status
- TERMINATED
- Phase
- N/A
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593)
- Status
- COMPLETED
- Phase
- PHASE4
PVSRIPO for Patients With Unresectable Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
- Status
- TERMINATED
- Phase
- N/A
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Status
- RECRUITING
- Phase
- N/A
A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma
- Status
- COMPLETED
- Phase
- N/A
Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma
- Status
- UNKNOWN
- Phase
- NA
Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Surgical Excision Margins in Thick Primary Melanoma - 2
- Status
- COMPLETED
- Phase
- NA
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2